Atrion Corporation (NASDAQ:ATRI) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07.
|
Submission of Matters to a Vote of Security Holders. |
On May 23, 2017, the Registrant held its 2017 annual meeting of
stockholders. Stockholders voted on the matters below.
| 1. |
Election of Directors. The nominees listed below were elected to serve as directors until the 2020 annual meeting of stockholders and until their successors are duly elected and qualified, based on the following votes: |
| Director | Votes For | Votes Withheld | Broker Non-Votes |
| Emile A Battat | 1,435,513 | 73,342 | 222,482 |
| Ronald N. Spaulding | 1,438,025 | 70,830 | 222,482 |
| 2. |
Ratification of Appointment of Independent Registered Public Accounting Firm. The Registrants stockholders ratified the appointment of Grant Thornton LLP as the Registrants independent registered public accounting firm for the year ending December 31, 2017, based on the following votes: |
| Votes For | Votes Against | Abstentions | Broker Non-Votes |
| 1,724,063 | 2,117 | 5,157 |
| 3. |
Advisory Vote to Approve Executive Officer Compensation. The Registrants stockholders approved, on an advisory basis, the compensation of the Registrants executive officers, based on the following votes: |
| Votes For | Votes Against | Abstentions | Broker Non-Votes |
| 1,231,359 | 271,057 | 6,439 | 222,482 |
| 4. |
Advisory Vote on Frequency of the Advisory Vote to Approve Executive Officer Compensation. As reflected in the votes set forth below, the Registrants stockholders expressed a preference that the advisory vote to approve executive officer compensation be held every year. |
| One Year | Two Years | Three Years | Abstain | Broker Non-Votes |
| 1,116,386 | 388,839 | 3,254 | 222,482 |
Based on these results, and the Board of Directors prior
recommendation, the Board of Directors has determined to continue
to hold an advisory vote to approve executive officer
compensation on an annual basis (i.e., every year).
About Atrion Corporation (NASDAQ:ATRI)
Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company’s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety. It has developed a range of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in areas, such as anesthesia and oncology. Its cardiovascular product, MPS2 Myocardial Protection System (MPS2), is the system used in open-heart surgery that delivers fluids and medications, mixes critical drugs and controls temperature, pressure and other variables. Atrion is a manufacturer of specialized medical devices that disinfect contact lenses. Its other medical and non-medical product lines consist of instrumentation and associated disposables. Atrion Corporation (NASDAQ:ATRI) Recent Trading Information
Atrion Corporation (NASDAQ:ATRI) closed its last trading session up +2.10 at 540.10 with 4,727 shares trading hands.
